Pathological Features and Survival Outcomes of Young Patients with Operable Colon Cancer: Are They Homogeneous?

Abstract

ObjectiveTo compare the pathological features and survival outcomes at different age subgroups of young patients with colon cancer.MethodsUsing Surveillance, Epidemiology, and End Results (SEER) population-based data, we identified 2,861 young patients with colon cancer diagnosed between 1988 and 2005 treated with surgery. Patients were divided into four groups: group 1 (below 25 years), group 2 (26–30 years), group 3 (31–35 years) and group 4 (36–40 years). Five-year cancer specific survival data were obtained. Kaplan-Meier methods were adopted and multivariable Cox regression models were built for the analysis of long-term survival outcomes and risk factors.ResultsThere were significant different among four groups in pathological grading, histological type, AJCC stage, current standard (≥12 lymph nodes retrieval), mean number of lymph nodes examined and positive lymph nodes (p<0.001). The 5-year cause specific survival was 71.0% in group 1, 75.1% in group 2, 80.6% in group 3 and 82.5% in group 4, which had significant difference in both univariate (P = 0.002) and multivariate analysis (P = 0.041).ConclusionsYoung patients with colon cancer at age 18–40 years are essentially a heterogeneous group. Patients at age 31–35, 36–40 subgroups have more favorable clinicopathologic characteristics and better cancer specific survival than below 30 years.

Age-specific impact on the survival of gastric cancer patients with distant metastasis: an analysis of SEER database

“…This study has several limitations. First, the SEER database does not include information of therapeutic options such as detailed information of chemotherapy, targeted therapy, immunotherapy, recurrence and metastasis, which may also impact patients’ prognosis [ 35 ]. Second, the SEER database is lack of detailed description of the organ metastasis (liver, lung, bone or brain).…”

FrequentBRAFmutation in early-onset colorectal cancer in Taiwan: association with distinct clinicopathological and molecular features and poor clinical outcome

“…Higher frequencies of mucinous adenocarcinoma and signet ring cell carcinoma (SRCC) have been seen in several studies 2 5 10–13. Discrepancies exist in the prognoses of patients with EOCRC.…”

“…Discrepancies exist in the prognoses of patients with EOCRC. Some studies have suggested a poorer prognosis in patients with EOCRC,2 4 14 whereas others have reported that their prognosis is similar to, or even more favourable than, that of patients with general CRC because they usually have a better performance status 1 3 6 11–13 15 16…”

Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal Cancer

“…When considering early onset CRC, the age definition of the group referred to as "adolescent and young adults" (AYA) is still debated [4]. Age cutoffs vary widely among published studies; some authors recommend an upper limit of 50 years of age, based on historically recommended CRC screening guidelines in the average-risk population, whereas others select patients below the age of 40 years based on physiological and pathological variables [5][6][7]. In addition, data on outcomes of younger patients with CRC are inconsistent, with reports showing either a worse or a better outcome when compared with their older counterparts [5][6][7].…”